Eupraxia Pharmaceuticals Financial Ratios for Analysis 2022-2024 | EPRX

Fifteen years of historical annual and quarterly financial ratios and margins for Eupraxia Pharmaceuticals (EPRX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
1.026.08
-0.55
11.711.25
--
--
--
--
--
--
--
--
--
--
-3,246.15-263.47
-3,246.12-263.47
-142.93-99.31
-3,246.12-118.22
0.030.33
-0.86-0.75
-0.86-0.76

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31
2.111.951.02----
0.00------
0.350.5311.71----
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-45.46-34.00-459.03----
-45.46-34.00-459.02----
-24.28-16.81-20.21----
-45.35-34.00-459.03----
0.370.510.03----
-0.39-0.21-0.860.00-0.40-0.210.00
-0.39-0.21-0.86--0.40-0.21-